NeoCircle: pre- and post-operative circulating tumor DNA dynamics predicts survival in neoadjuvant-treated early breast cancer.
Saved in:
| Title: | NeoCircle: pre- and post-operative circulating tumor DNA dynamics predicts survival in neoadjuvant-treated early breast cancer. |
|---|---|
| Authors: | George AM; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden.; Center for Interdisciplinary Research on Cancer and Equity in Women, Lund University, Lund, Sweden.; SAGA Diagnostics, Morrisville, NC, USA., Chen Y; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden.; SAGA Diagnostics, Morrisville, NC, USA., Gladchuk S; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden.; Center for Interdisciplinary Research on Cancer and Equity in Women, Lund University, Lund, Sweden.; SAGA Diagnostics, Morrisville, NC, USA., Alcaide M; SAGA Diagnostics, Morrisville, NC, USA., Dalal H; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden., Meng P; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden., Brueffer C; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden.; Center for Interdisciplinary Research on Cancer and Equity in Women, Lund University, Lund, Sweden., Saghir H; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden.; SAGA Diagnostics, Morrisville, NC, USA., Kimbung S; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden.; Center for Interdisciplinary Research on Cancer and Equity in Women, Lund University, Lund, Sweden., Aaltonen K; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden., Oton L; SAGA Diagnostics, Morrisville, NC, USA., Rushton C; SAGA Diagnostics, Morrisville, NC, USA., Birkeälv S; SAGA Diagnostics, Morrisville, NC, USA., Jönsson M; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden., Zackrisson S; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden.; Center for Interdisciplinary Research on Cancer and Equity in Women, Lund University, Lund, Sweden.; Diagnostic Radiology, Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Imaging and Physiology, Skåne University Hospital, Malmö, Sweden., Skarping I; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden.; Center for Interdisciplinary Research on Cancer and Equity in Women, Lund University, Lund, Sweden., Förnvik D; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden.; Center for Interdisciplinary Research on Cancer and Equity in Women, Lund University, Lund, Sweden.; Medical Radiation Physics, Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund/Malmö, Sweden., Zander L; Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund/Malmö, Sweden., Honeth G; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden.; Department of Pathology, Skåne University Hospital, Lund, Sweden., Woodhouse S; SAGA Diagnostics, Morrisville, NC, USA., Howarth K; SAGA Diagnostics, Morrisville, NC, USA., Borg Å; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden., Ehinger A; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden.; Department of Pathology, Skåne University Hospital, Lund, Sweden., Malmberg M; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden., Rydén L; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden.; Center for Interdisciplinary Research on Cancer and Equity in Women, Lund University, Lund, Sweden.; Department of Surgery, Skåne University Hospital, Lund, Sweden., Loman N; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund University Cancer Center, Lund, Sweden.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden.; Center for Interdisciplinary Research on Cancer and Equity in Women, Lund University, Lund, Sweden.; Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund/Malmö, Sweden., Saal LH; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden. lao.saal@med.lu.se.; Lund University Cancer Center, Lund, Sweden. lao.saal@med.lu.se.; Skåne University Hospital Comprehensive Cancer Center, Lund, Sweden. lao.saal@med.lu.se.; Center for Interdisciplinary Research on Cancer and Equity in Women, Lund University, Lund, Sweden. lao.saal@med.lu.se. |
| Source: | EMBO molecular medicine [EMBO Mol Med] 2026 Jul; Vol. 18 (7), pp. 2617-2634. Date of Electronic Publication: 2026 May 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
